Related Experiment Video

Updated: Jun 10, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease

Tianhua Yang1, Dong Zhou, Hermann Stefan

  • 1Department of Neurology, West China Hospital, Si Chuan University, Cheng du, Sichuan, China.

Journal of the Neurological Sciences
|July 29, 2010
PubMed

Insights

Uncontrolled inflammation may drive the progression of mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). Targeting this inflammation could offer new therapeutic strategies for managing seizures and disease advancement.

Area of Science:

  • Neurology
  • Neuroscience
  • Epilepsy Research

Background:

  • Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is a chronic neurological disorder.
  • Evidence suggests MTLE-HS may be a progressive disease, but underlying mechanisms are unclear.
  • Inflammation is increasingly implicated in the pathogenesis of MTLE.

Purpose of the Study:

  • To review existing literature on the role of uncontrolled inflammation in MTLE-HS progression.
  • To explore the potential of targeting inflammatory processes as a therapeutic strategy.

Main Methods:

  • Literature review of studies investigating inflammation in MTLE-HS.
  • Analysis of the relationship between inflammation, blood-brain barrier damage, and seizure activity.

Main Results:

  • Growing evidence links uncontrolled inflammation to disease progression in MTLE-HS.
  • Uncontrolled inflammation may fuel a cycle involving blood-brain barrier damage and seizures.
  • This cycle appears to drive the progressive nature of MTLE-HS.

Conclusions:

  • Uncontrolled inflammation is a key factor in the progressive nature of MTLE-HS.
  • Modulating inflammatory processes presents a potential novel therapeutic strategy.
  • Targeting inflammation may offer new avenues for seizure pharmacotherapy and slowing disease progression.

More Related Videos

In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy (pCLE) of Hippocampal Capillaries in Awake Mice09:08

In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy (pCLE) of Hippocampal Capillaries in Awake Mice

Published on: April 21, 2023

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...